Miniature In-line Respirator
Part of paid clinical trials in Philadelphia, Pennsylvania.
- Sponsor
- National Institutes of Health Clinical Center (CC)
- Study ID
- NCT07768215
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Brain Death
- Respiration, Artificial
Eligibility Criteria
- Sex
- ALL
- Age
- 1 Year - 100 Years
- Healthy Volunteers
- Not accepted
Interventions
- Hope inVent — DEVICEThe Hope inVent is an investigational, single-use, miniature in-line respirator designed to provide short-term ventilatory support for intubated individuals. The device is a 3D-printed, pressure-cycled, gas-powered respirator with no moving parts. It connects to the endotracheal tube breathing circuit and uses compressed oxygen as its power source. In this study, only the Green Hope inVent model will be used. The device cycles between fixed pressure settings: peak inspiratory pressure of 18 cm H2O and positive end-expiratory pressure of 6 cm H2O. Enrolled brain-dead research donors will be placed on the device once for up to 15 minutes, with continuous respiratory and physiologic monitoring. The donor will then be returned to the standard mechanical ventilator.
Study Details
This first-in-human pilot study will test an investigational miniature breathing device called the Hope inVent. The device is a small, single-use, in-line respirator that connects to a breathing tube and uses compressed oxygen to help move air in and out of the lungs. It has no moving parts and is designed to provide short-term breathing support in situations where standard ventilators may not be available, such as emergencies, disasters, battlefield settings, transport, or ventilator shortages. The study will enroll up to 5 brain-dead organ donors who are already receiving mechanical ventilation at the Gift of Life Donor Care Center at the Hospital of the University of Pennsylvania. Donors will only be included after authorization for organ donation and research has been obtained through standard procedures. Donors who may donate lungs or who have significant lung disease will not be included. During the study, investigators will briefly replace the standard ventilator with the Hope inVent device for up to 15 minutes. The standard ventilator will remain immediately available, and the donor will be continuously monitored by the clinical and research teams. Investigators will measure whether the device can maintain acceptable breathing measures, including oxygen level and carbon dioxide level. They will also record breathing pressures and tidal volume, which is the amount of air delivered with each breath. If the device does not perform as expected or if any safety concern occurs, the donor will be returned immediately to the standard ventilator. There is no direct benefit to the organ donor. Information from this study may help determine whether this type of simple, low-cost breathing device could be useful for future patients who need emergency or short-term ventilator support when standard ventilators are not available.
Key Dates
- First listed
- Aug 17, 2026
- Start date
- Aug 20, 2026
- Status verified
- Aug 2026
- Primary completion
- Dec 1, 2028
- Completion
- Dec 1, 2028
Study Design
- Enrollment
- 5 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DEVICE_FEASIBILITY
Arms
- Experimental: Hope inVent Miniature In-line RespiratorAll enrolled brain-dead organ donors who meet eligibility criteria will receive the investigational Green Hope inVent miniature in-line, pressure-cycled respirator for up to 15 minutes. Respiratory and physiologic measures will be collected before device placement while the donor is on the standard mechanical ventilator and during use of the Hope inVent device. Each donor serves as their own control; there is no separate comparator arm. The standard ventilator will remain available, and donors will be returned to standard ventilation after testing or earlier if safety or performance criteria require.
Primary Outcome Measure
Proportion of donors with successful ventilation and oxygenation during Hope inVent testing. [ Time Frame: During device use, from connection of the Hope inVent device to removal, up to 15 minutes. ]
Central Contacts
- Tracy S Williams, R.N.(301) 448-5366
- Andrew J Mannes, M.D.(301) 594-3427
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Hospital of the University of Pennsylvania | Philadelphia | Pennsylvania | 19104 |
Find similar trials in Philadelphia, PA
Related Studies
- Telehealth-Enabled, Real-time Audit and Feedback for Clinician AdHerence (TEACH)Recruiting · Intermountain Health Care, Inc. · American Fork, Utah
- Non-inferiority Trial Between Sotair® Device Attached to Manual Resuscitator Versus Mechanical VentilationRecruiting · Rhode Island Hospital · Providence, Rhode Island
- Optimal Timing for Spontaneous Breathing TrialsRecruiting · Rush University Medical Center · Chicago, Illinois